BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 29 filers reported holding BIOLINERX LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $33,000 | -38.9% | 76,927 | -37.8% | 0.00% | – |
| Q4 2018 | $54,000 | -44.9% | 123,724 | +14.7% | 0.00% | – |
| Q2 2018 | $98,000 | -22.2% | 107,827 | -27.2% | 0.00% | – |
| Q2 2017 | $126,000 | -90.9% | 148,038 | -89.7% | 0.00% | -100.0% |
| Q1 2017 | $1,386,000 | +2375.0% | 1,442,546 | +2867.7% | 0.00% | – |
| Q3 2016 | $56,000 | +40.0% | 48,608 | +24.0% | 0.00% | – |
| Q1 2016 | $40,000 | – | 39,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,501,000 | $2,432,000 | 0.47% |
| Senvest Management, LLC | 2,278,995 | $3,692,000 | 0.26% |
| Opaleye Management Inc. | 250,000 | $405,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 928,758 | $1,505,000 | 0.05% |
| Benchmark Capital Advisors | 40,000 | $65,000 | 0.04% |
| Orbimed Advisors | 1,135,000 | $1,839,000 | 0.02% |
| NEXT Financial Group, Inc | 28,500 | $46,000 | 0.02% |
| Cutter & CO Brokerage, Inc. | 10,000 | $16,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 110 | $0 | 0.00% |
| Renaissance Technologies | 26,878 | $44,000 | 0.00% |